Drug Profile
PC 114
Alternative Names: PC-114Latest Information Update: 28 Sep 2020
Price :
$50
*
At a glance
- Originator PinCell
- Class Anti-inflammatories; Skin disorder therapies
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes - Psoriasis
Highest Development Phases
- No development reported Psoriasis
Most Recent Events
- 28 Sep 2020 No recent reports of development identified for research development in Psoriasis in Italy (Topical)
- 15 Aug 2016 PC 114 is available for licensing as of 15 Aug 2016. https://sites.google.com/site/pincellsite/
- 15 Aug 2016 Early research in Psoriasis in Italy (Topical)